Related Experiment Video
Updated: Jan 28, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
The pathogenesis, diagnosis and management of congenital dyserythropoietic anaemia type I
Noémi B A Roy1,2,3, Christian Babbs1
1MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Insights
Congenital dyserythropoietic anaemia type I (CDA-I) is a rare inherited blood disorder. Genetic testing aids in faster diagnosis and management, improving patient outcomes through a multidisciplinary approach.
Area of Science:
- Hematology
- Genetics
- Molecular Biology
Background:
- Congenital dyserythropoietic anaemia type I (CDA-I) is an inherited disorder affecting red blood cell production.
- It is caused by mutations in CDAN1 or C15orf41, with 56 mutations identified.
Purpose of the Study:
- To review the diagnostic pathway for CDA-I.
- To highlight the benefits of genetic testing for timely molecular diagnosis and avoiding bone marrow aspiration.
- To discuss management strategies for improving disease outcomes.
Main Methods:
- Review of diagnostic pathways for CDA-I.
- Analysis of genetic testing utility.
- Discussion of management strategies including interferon alpha and iron overload management.
- Presentation of current understanding of molecular pathogenesis.
Main Results:
- Genetic testing can expedite accurate molecular diagnosis of CDA-I.
- Avoiding bone marrow aspiration is possible in some cases through genetic testing.
- Holistic, multidisciplinary management, including interferon alpha and iron overload control, leads to better outcomes.
Conclusions:
- Genetic testing is crucial for efficient CDA-I diagnosis and management.
- A multidisciplinary approach is essential for optimizing patient outcomes in CDA-I.
- Further research into CDA-I pathogenesis is needed for improved therapies.
Abstract:
Congenital dyserythropoietic anaemia type I (CDA-I) is one of a heterogeneous group of inherited anaemias characterised by ineffective erythropoiesis. CDA-I is caused by bi-allelic mutations in either CDAN1 or C15orf41 and, to date, 56 causative mutations have been documented. The diagnostic pathway is reviewed and the utility of genetic testing in reducing the time taken to reach an accurate molecular diagnosis and avoiding bone marrow aspiration, where possible, is described. The management of CDA-I patients is discussed, highlighting both general and specific measures which impact on disease progression. The use of interferon alpha and careful management of iron overload are reviewed and suggest the most favourable outcomes are achieved when CDA-I patients are managed with a holistic and multidisciplinary approach. Finally, the current understanding of the molecular and cellular pathogenesis of CDA-I is presented, highlighting critical questions likely to lead to improved therapy for this disease.
Related Concept Videos
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Nursing Diagnosis
The nursing diagnosis focuses on evidence-based...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Documentation of Nursing Diagnosis
In some settings, data-driven computerized decision support systems are in place, allowing for more accurate nursing diagnoses. The database within one of these systems includes diagnostic labels defining characteristics, activities, and indicators for nursing. A nurse enters...

